BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19496118)

  • 21. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention of restenosis.
    Li H; Zhong H; Xu K; Yang K; Liu J; Zhang B; Zheng F; Xia Y; Tan L; Hong D
    J Endovasc Ther; 2011 Jun; 18(3):407-15. PubMed ID: 21679083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of a stent covered with biosynthetic cellulose in a rabbit iliac artery model.
    Bueno RR; Tanguay JF; Brito FS; Guerios EE; Tarastchuk JE; Sanches PA; Andrade PM; Rossi PF; Bueno FL
    J Invasive Cardiol; 2009 Aug; 21(8):392-6. PubMed ID: 19652252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.
    Ruiter MS; van Tiel CM; Doornbos A; Marinković G; Strang AC; Attevelt NJ; de Waard V; de Winter RJ; Steendam R; de Vries CJ
    PLoS One; 2015; 10(9):e0138459. PubMed ID: 26389595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
    Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
    J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
    John MC; Wessely R; Kastrati A; Schömig A; Joner M; Uchihashi M; Crimins J; Lajoie S; Kolodgie FD; Gold HK; Virmani R; Finn AV
    JACC Cardiovasc Interv; 2008 Oct; 1(5):535-44. PubMed ID: 19463356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
    Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
    Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts.
    Wong G; Li JM; Hendricks G; Eslami MH; Rohrer MJ; Cutler BS
    J Vasc Surg; 2008 Mar; 47(3):608-15. PubMed ID: 18295112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.
    Sauter A; Landers A; Dittmann H; Pritzkow M; Wiesinger B; Bayer M; Bantleon R; Schmehl J; Claussen CD; Kehlbach R
    J Vasc Interv Radiol; 2011 May; 22(5):623-9. PubMed ID: 21414804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
    Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
    JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
    Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
    Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue Factor Pathway Inhibitor-Coated Stents Inhibit Restenosis in a Rabbit Carotid Artery Model.
    Shi M; Yin F; Gu H; Zhu J; Yin X
    Cardiovasc Ther; 2015 Dec; 33(6):353-9. PubMed ID: 26280363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter.
    Lemos PA; Farooq V; Takimura CK; Gutierrez PS; Virmani R; Kolodgie F; Christians U; Kharlamov A; Doshi M; Sojitra P; van Beusekom HM; Serruys PW
    EuroIntervention; 2013 May; 9(1):148-56. PubMed ID: 23685303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats.
    Pozo M; Izquierdo MC; de Nicolás R; Egido J; Ortiz A; González-Cabrero J
    J Vasc Res; 2009; 46(4):278-89. PubMed ID: 19033690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
    Visconti G; Taranto D; Briguori C
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):873-6. PubMed ID: 19009632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.